...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Potential

,,,accchhhh,,Don said this and Don said that,,,whats not to understand after all these years of presentations to shareholders that Don's saids can be purdy well classified as being worthless,,,,,,,as the stock price of both of his companies confirm in real present time. We trade for the worth of our tax loss to a real Pharma. Its juts an observation from living and being part owner in this nightmare!

Share
New Message
Please login to post a reply